The pharmaceutical industry has increasingly taken aim at the program for growing costs, but is that accurate? American Hospital Association analysts offer this perspective.
Megha Parikh, PhD, MS
Advertisement
Articles by Megha Parikh, PhD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
2026 Medicare Physician Fee Schedule: Payment up 2.5% as CMS shifts from ‘sick-care’ to health care
2
2026 Medicare Physician Fee Schedule: A policy ‘grab bag’ that hurts independent practice, telehealth regulations
3
MMR confusion; in utero COVID exposure linked to autism; the 2025 biotech graveyard – Morning Medical Update
4
2025 Revenue Cycle Management Survey insights
5
